133 related articles for article (PubMed ID: 29137341)
1. Clinicopathological significance of the
Yu H; Yang L; Fu Y; Gao M; Tian L
Oncotarget; 2017 Oct; 8(47):83270-83279. PubMed ID: 29137341
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological significance of p15 promoter hypermethylation in multiple myeloma: a meta-analysis.
Wei B; Yang S; Zhang B; Feng Y
Onco Targets Ther; 2016; 9():4015-22. PubMed ID: 27445492
[TBL] [Abstract][Full Text] [Related]
3. Aberrant gene methylation implicated in the progression of monoclonal gammopathy of undetermined significance to multiple myeloma.
Chim CS; Liang R; Leung MH; Kwong YL
J Clin Pathol; 2007 Jan; 60(1):104-6. PubMed ID: 17213358
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological significance and potential drug target of p15INK4B in multiple myeloma.
Li J; Bi L; Lin Y; Lu Z; Hou G
Drug Des Devel Ther; 2014; 8():2129-36. PubMed ID: 25382971
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylation of the p16 gene in sporadic T3N0M0 stage colorectal cancers: association with DNA replication error and shorter survival.
Liang JT; Chang KJ; Chen JC; Lee CC; Cheng YM; Hsu HC; Wu MS; Wang SM; Lin JT; Cheng AL
Oncology; 1999; 57(2):149-56. PubMed ID: 10461063
[TBL] [Abstract][Full Text] [Related]
6. Aberrant promoter hypermethylation of p16 gene in endometrial carcinoma.
Hu ZY; Tang LD; Zhou Q; Xiao L; Cao Y
Tumour Biol; 2015 Mar; 36(3):1487-91. PubMed ID: 25596080
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance and potential drug target of T-cadherin in NSCLC.
Wang Z; Wang B; Guo H; Shi G; Hong X
Drug Des Devel Ther; 2015; 9():207-16. PubMed ID: 25565774
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis.
Kawaguchi K; Oda Y; Saito T; Yamamoto H; Tamiya S; Takahira T; Miyajima K; Iwamoto Y; Tsuneyoshi M
J Pathol; 2003 Nov; 201(3):487-95. PubMed ID: 14595762
[TBL] [Abstract][Full Text] [Related]
9. Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung.
Kim JS; Kim H; Shim YM; Han J; Park J; Kim DH
Carcinogenesis; 2004 Nov; 25(11):2165-71. PubMed ID: 15231689
[TBL] [Abstract][Full Text] [Related]
10. Aberrant gene promoter methylation in plasma cell dyscrasias.
Martin P; Garcia-Cosio M; Santon A; Bellas C
Exp Mol Pathol; 2008 Jun; 84(3):256-61. PubMed ID: 18410922
[TBL] [Abstract][Full Text] [Related]
11. Methylation profile of promoter region of p16 gene in colorectal cancer patients of Kashmir valley.
Wani HA; Beigh MA; Amin S; Bhat AA; Bhat S; Khan H; Mattoo AA; Showkat M; Masood A; Majid S
J Biol Regul Homeost Agents; 2013; 27(2):297-307. PubMed ID: 23830381
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications.
Gonzalez-Paz N; Chng WJ; McClure RF; Blood E; Oken MM; Van Ness B; James CD; Kurtin PJ; Henderson K; Ahmann GJ; Gertz M; Lacy M; Dispenzieri A; Greipp PR; Fonseca R
Blood; 2007 Feb; 109(3):1228-32. PubMed ID: 16840723
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional silencing of the p16 gene in human myeloma-derived cell lines by hypermethylation.
Wong IH; Ng MH; Lee JC; Lo KW; Chung YF; Huang DP
Br J Haematol; 1998 Oct; 103(1):168-75. PubMed ID: 9792305
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of p16INK4a by CpG hypermethylation is not a frequent event in colorectal cancer.
Norrie MW; Hawkins NJ; Todd AV; Meagher AP; O'Connor TW; Ward RL
J Surg Oncol; 2003 Nov; 84(3):143-50. PubMed ID: 14598358
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of NOTCH1 and JAGGED1 expression in multiple myeloma and monoclonal gammopathy of undetermined significance.
Skrtić A; Korać P; Krišto DR; Ajduković Stojisavljević R; Ivanković D; Dominis M
Hum Pathol; 2010 Dec; 41(12):1702-10. PubMed ID: 20800871
[TBL] [Abstract][Full Text] [Related]
16. Aberrant methylation of the p16 gene is frequently detected in advanced colorectal cancer.
Goto T; Mizukami H; Shirahata A; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
Anticancer Res; 2009 Jan; 29(1):275-7. PubMed ID: 19331161
[TBL] [Abstract][Full Text] [Related]
17. Loss of p16 protein expression associated with methylation of the p16INK4A gene is a frequent finding in Hodgkin's disease.
García JF; Villuendas R; Algara P; Sáez AI; Sánchez-Verde L; Martínez-Montero JC; Martínez P; Piris MA
Lab Invest; 1999 Dec; 79(12):1453-9. PubMed ID: 10616196
[TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
19. p16INK4A alterations are accompanied by aberrant protein immunostaining in endometrial carcinomas.
Semczuk A; Boltze C; Marzec B; Szczygielska A; Roessner A; Schneider-Stock R
J Cancer Res Clin Oncol; 2003 Oct; 129(10):589-96. PubMed ID: 12920579
[TBL] [Abstract][Full Text] [Related]
20. KRAS, BRAF oncogene mutations and tissue specific promoter hypermethylation of tumor suppressor SFRP2, DAPK1, MGMT, HIC1 and p16 genes in colorectal cancer patients.
Bagci B; Sari M; Karadayi K; Turan M; Ozdemir O; Bagci G
Cancer Biomark; 2016 Jun; 17(2):133-43. PubMed ID: 27540971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]